Melanie Thomas, MD, is a medical oncologist, clinical researcher, and Associate Director for Experimental Therapeutics at Gibbs Cancer Center & Research Institute, Spartanburg Regional Healthcare System, Spartanburg, South Carolina. Her research has included clinical trials in solid tumors through the National Cancer Institute (NCI), pharmaceutical industry, NCTN cooperative groups, investigator initiated, and Phase I trials of novel agents, all of which have been published in peer-reviewed oncology journals. Dr. Thomas has led numerous clinical trials in hepatocellular carcinoma and other gastrointestinal cancers and is an internationally recognized expert in these malignancies. She received the NCI Clinical Investigator Team Leadership Award 2009-2010.
Dr. Thomas attended Boston University School of Medicine, completed internal medicine residency at The Beth Israel Deaconess Medical Center in Boston, and spent nine years at The University of Texas M.D. Anderson Cancer Center as a medical oncology fellow and faculty member. Previously she was Associate Director, Clinical Investigations, Hollings Cancer Center, Medical University of South Carolina. From 2007-2014 she was President of CanLiv – The Hepatobiliary Cancers Foundation, now part of The Global Liver Institute.